This is for the naysayers who believe that there is no scientific evidence that intravenous vitamin C, vitamin C given in a vein, does not better help (and even cure) a variety of devastating conditions:
Oral vitamin C, like vitamin C pill and orange juice, does not achieve as much for your health as vitamin C does intravenously. Intravenous vitamin C has been helped patients with cancer, arthritis, heart disease, infections, fatigue, joint pain, intestinal disease and more. See the links below for reasons why intravenous vitamin C is hugely helpful.
More will be posted about the controversy over intravenous C and why the FDA is trying to prevent you from getting it.
SCIENTIFIC REFERENCES – INTRAVENOUS VITAMIN C
http://www.ncbi.nlm.nih.gov/pubmed/20628650 – Shows that intravenous vitamin C is “remarkably safe (when given intravenously)”.
http://www.ncbi.nlm.nih.gov/pubmed/20511723 – Intravenous vitamin C kills cancer cells by producing hydrogen peroxide.
http://www.ncbi.nlm.nih.gov/pubmed/20424557 – Intravenous vitamin C for the treatment of herpetic neuralgia.
http://www.ncbi.nlm.nih.gov/pubmed/20400857 – Intravenous vitamin C reaches much higher blood levels than oral vitamin C could ever reach.
http://www.ncbi.nlm.nih.gov/pubmed/20171954 – In vivo experiment, intravenous administration of ascorbic acid significantly decreased the growth rate of mesothelioma tumor inoculated in mice. These data suggest that ascorbic acid may have benefits for patients with mesothelioma.
http://www.ncbi.nlm.nih.gov/pubmed/20170881 – Impaired microcirculatory reperfusion is improved by vitamin C infusion suggesting that oxidative stress is implicated
http://www.ncbi.nlm.nih.gov/pubmed/20150992 – Conclude that the inhibition of angiogenesis by ascorbate suggested in vitro is confirmed in vivo, and that angiogenesis inhibition may be one mechanism by which intravenous ascorbate therapy shows efficacy in animal experiments and clinical case studies.
http://www.ncbi.nlm.nih.gov/pubmed/19731754 – High dose intravenous vitamin C therapy may have benefits in patients with advanced cancers, and cancers with poor prognosis and limited therapeutic options, but further clinical studies regarding the safety and efficacy of this therapy are necessary, especially in Germany.
http://www.ncbi.nlm.nih.gov/pubmed/16567755 – “Early clinical studies showed that high-dose vitamin C, given by intravenous and oral routes, may improve symptoms and prolong life in patients with terminal cancer”.
http://www.ncbi.nlm.nih.gov/pubmed/18450228 – “This review describes the current state-of-the-art in oral and intravenous vitamin C pharmacokinetics. In addition, the governmental recommendations of dose and frequency of vitamin C intake will also be addressed”.
http://www.ncbi.nlm.nih.gov/pubmed/17053422 – Supraphysiological levels of ascorbate, which can only be achieved by the parenteral and not by the oral administration of vitamin C, may facilitate the restoration of vascular function in the critically ill patient.
http://www.ncbi.nlm.nih.gov/pubmed/19284416 – (For Acute Myeloid Leukemia) – The clinical benefit, along with a conspicuous absence of significant adverse events, suggests that further testing of LAA depletion alternating with pharmacologic dose intravenous supplementation in patients with these and other malignancies is warranted.
http://www.ncbi.nlm.nih.gov/pubmed/12410623 – Research into Intravenous Myer’s Coctail.
http://www.ncbi.nlm.nih.gov/pubmed/18468413 – Interstitial pneumonia can be controlled by the combined use of a prophylactic antibiotic system and the drip infusion system including megadose vitamin C.
http://www.ncbi.nlm.nih.gov/pubmed/19246295 – Intravenous administration of 2.83 g/kg vitamin C can promote the necrosis and apoptosis of hepatoma Walker256 cells in rats and protect the liver function of the tumor-bearing rats.
http://www.ncbi.nlm.nih.gov/pubmed/19154961 – High dosages of vitamin C will not increase stones in a person with normal kidney function.
http://www.ncbi.nlm.nih.gov/pubmed/19414313 – Intravenous vitamin C helps advanced cancers.
http://www.ncbi.nlm.nih.gov/pubmed/18974579 – Vitamin C helps hemodialysis patients.
http://www.ncbi.nlm.nih.gov/pubmed/12803508 – Intravenous vitamin C helps remove excessive bound iron.
http://www.ncbi.nlm.nih.gov/pubmed/18938145 – Intravenous vitamin C can kill cancer cells.
http://www.ncbi.nlm.nih.gov/pubmed/18830869 – Intravenous vitamin C helps hyperpigmentation.
http://www.ncbi.nlm.nih.gov/pubmed/18705014 – Intravenous vitamin C
http://www.ncbi.nlm.nih.gov/pubmed/18678913 – “These data suggest that ascorbate as a prodrug may have benefits in cancers with poor prognosis and limited therapeutic options”.
http://www.ncbi.nlm.nih.gov/pubmed/17502596 – “By using the synthesized probe peroxyxanthone, H(2)O(2) in extracellular fluid was detected only after parenteral administration of ascorbate and when Asc(*-) concentrations in extracellular fluid exceeded 100 nM. The data show that pharmacologic ascorbate is a prodrug for preferential steady-state formation of Asc(*-) and H(2)O(2) in the extracellular space but not blood”.
http://www.ncbi.nlm.nih.gov/pubmed/16157892 – “Findings give plausibility to i.v. ascorbic acid in cancer treatment, and have unexpected implications for treatment of infections where H(2)O(2) may be beneficial.”
http://www.ncbi.nlm.nih.gov/pubmed/20068072 – These results show that pharmacologic doses of ascorbate, easily achievable in humans, may have potential for therapy in pancreatic cancer.
http://www.ncbi.nlm.nih.gov/pubmed/18544557 – “High-dose i.v. ascorbic acid was well tolerated but failed to demonstrate anticancer activity when administered to patients with previously treated advanced malignancies. The promise of this approach may lie in combination with cytotoxic or other redox-active molecules”.
http://www.ncbi.nlm.nih.gov/pubmed/19414313 – High Dose vitamin C in advanced cancer.
http://www.ncbi.nlm.nih.gov/pubmed/12013679 – Cancer and intravenous vitamin C.
http://www.ncbi.nlm.nih.gov/pubmed/18450228 – The significance of intravenous vitamin C administration.
http://www.ncbi.nlm.nih.gov/pubmed/17965239 – Results support the hypothesis that oxidative stress plays a major role in the reduced resting whole leg blood flow and increased leg vasoconstriction observed with aging in men.
http://www.ncbi.nlm.nih.gov/pubmed/17892985 – Vitamin C improves heart function.
http://www.ncbi.nlm.nih.gov/pubmed/17297243 – Vitamin C is considered a safe and effective therapy to improve the quality of life of terminal cancer patients.
http://www.ncbi.nlm.nih.gov/pubmed/16116933 – Ascorbate concentrations sufficient to kill tumor cells can be safely achieved in solid tumors in vivo, suggesting a possible role for high dose intravenous ascorbate in treating cancer.
http://www.ncbi.nlm.nih.gov/pubmed/15806791 – Vitamin C can kill cancer cells and may also assist chemotherapy.
